必须声明标量变量 "@Script_ID"。 益生菌联合辅舒良治疗变态反应性鼻炎合并哮喘患者的临床疗效-《赣南医学院学报》

[1]裘海燕a,温晓茂,孙龙华.益生菌联合辅舒良治疗变态反应性鼻炎合并哮喘患者的临床疗效[J].赣南医学院学报,2019,39(12):1217-1219.[doi:10.3969/j.issn.1001-5779.2019.12.007]
 QIU Hai-yana,WEN Xiao-mao,SUN long-hua.Clinical effect of probiotics combined with fushuliang on patients with allergic rhinitis combined with asthma[J].,2019,39(12):1217-1219.[doi:10.3969/j.issn.1001-5779.2019.12.007]
点击复制

益生菌联合辅舒良治疗变态反应性鼻炎合并哮喘患者的临床疗效()
分享到:

《赣南医学院学报》[ISSN:1001-5779/CN:36-1154/R]

卷:
39
期数:
2019年12期
页码:
1217-1219
栏目:
临床研究
出版日期:
2019-12-31

文章信息/Info

Title:
Clinical effect of probiotics combined with fushuliang on patients with allergic rhinitis combined with asthma
文章编号:
1001-5779(2019)12-1217-03
作者:
裘海燕1a温晓茂1孙龙华2
1.南昌市新建区人民医院 a.呼吸科; 2.南昌市中西医结合医院呼吸科,江西 南昌 330000
Author(s):
QIU Hai-yan1a WEN Xiao-mao1 SUN long-hua2
1.Xinjian District People's Hospital a.Department of respiratory medicine; 2.Department of respiratory medicine, integrated traditional Chinese and western medicine hospital, Nanchang, Jiangxi 330000
关键词:
变态反应性鼻炎 哮喘 辅舒良 益生菌
Keywords:
allergic rhinitis Asthma FuShuLiang Probiotics
分类号:
R562
DOI:
10.3969/j.issn.1001-5779.2019.12.007
文献标志码:
A
摘要:
目的:观察益生菌联合辅舒良治疗变态反应性鼻炎合并哮喘的临床疗效。方法:将2018年1-12月期间收治的变态反应性鼻炎合并哮喘的患儿60例,采用随机数字表法将患儿分为对照组和观察组,每组30例。对照组采用辅舒良治疗,观察者在对照组的基础上加用口服双歧杆菌乳杆菌四联活菌片治疗。3个月后统计治疗疗效。结果:对照组和观察组总有效率分别为90.0%、96.7%,两组比较,差异有统计学意义(P<0.05)。两组治疗后变态反应性鼻炎、哮喘等症状总积分和均有明显改善,观察组评分改善程度优于对照组,差异均有统计学意义(P<0.01)。结论:在应用辅舒良基础上加用口服双歧杆菌乳杆菌四联活菌片治疗变态反应性鼻炎合并哮喘具有较好的临床疗效。
Abstract:
Objective: To observe the clinical effect of probiotics combined with fushuliang in the treatment of allergic rhinitis combined with asthma. Methods: 60 children with allergic rhinitis combined with asthma admitted from January 2018 to December 2018 were divided into control group and observation group by random number table method, with 30 cases in each group. The control group was treated with coxurium, and the observer was treated with oral lactobacillus bifidum tetracyclovir tablets on the basis of the control group. The therapeutic effect was calculated 3 months later. Results: according to statistics, the total effective rate of the control group and the observation group was 90.0% and 96.7% respectively, and the difference was statistically significant(P<0.05). After treatment, the total scores of allergic rhinitis, asthma and other symptoms in the two groups were significantly improved, and the improvement degree of the observation group was better than that of the control group, with statistically significant differences(P<0.01). Conclusions: It is effective to treat allergic rhinitis combined with asthma with oral lactobacillus bifidum tetra live bacteria tablets on the basis of fushuliang.

参考文献/References:

[1] Nelson H S, Makatsori M, Calderon M A, et al. Subcutaneous immunotherapy and sublingual immunotherapy comparative efficacy, current and potential indications, and warnings-united States versus Europe[J]. Immunol Allergy ClinNorth An,2016,36(1):13-24.
[2] 葛均波,徐水健.内科学[M].第8版.北京:人民卫生出版社,2013:21-28.
[3] 乔燕,刘涛.益生菌对变应性疾病作用机制的研究进展[J].临床耳鼻咽喉头颈外科杂志,2016,30(18):1494-1498.
[4] 中华医学会耳鼻咽喉科学分会.变应性鼻炎诊断标准及疗效评定标准(1997年修订,海口)[J].中华耳鼻喉科杂志,1998,33(3):134-135.
[5] 中华医学会呼吸病学会哮喘学组.支气管哮喘防治指南[S].中华结核和呼吸杂志,2018,31(3):177-185.
[6] 凌圣,万文蓉.中成药结合丙酸氟替卡松治疗过敏性鼻炎对患者生理功能的影响[J].河北医药,2017,39(3):422-424.
[7] 邱文海,邓邵敏,刘翰翔,等.双歧杆菌乳杆菌三联活菌片联合孟鲁司特钠咀嚼片治疗支气管哮喘合并变应性鼻炎患者的临床疗效分析[J].实用心脑肺血管病杂志,2018,2(26):111-113.

相似文献/References:

[1]周小斌,蒋孔斐.综合康复指导对老年哮喘患者肺功能的影响[J].赣南医学院学报,2014,(06):858.
 ZHOU Xiao-bin,JIANG Kong-fei.Effects of Comprehensive Rehabilitation Instruction on Pulmonary Function in Elderly Patients with Asthma[J].,2014,(12):858.
[2]熊亚军,金日群,彭韶平.IL-20亚家族在变应性气道炎性疾病中的研究现状[J].赣南医学院学报,2019,39(09):954.[doi:10.3969/j.issn.1001-5779.2019.09.023]
 XIONG Ya-jun,JIN Ri-qun,PENG Shao-ping.Current status of IL-20 subfamily in allergic airway inflammatory diseases[J].,2019,39(12):954.[doi:10.3969/j.issn.1001-5779.2019.09.023]

备注/Memo

备注/Memo:
基金项目:江西省卫生计划生育委员会科技计划项目(编号:20187036)
作者简介:裘海燕,女,硕士,主治医师,研究方向:肺部感染和慢性阻塞性肺疾病。E-mail:531586571@qq.com
更新日期/Last Update: 2019-12-30